Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 47.93
(-0.15%)
CNY 47.93
(-0.15%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -953.41 Million CNY | 21.62% |
| 2022 | -1.21 Billion CNY | 19.27% |
| 2021 | -1.5 Billion CNY | -10.28% |
| 2020 | -1.36 Billion CNY | 37.94% |
| 2019 | -2.2 Billion CNY | -170.48% |
| 2018 | -813.91 Million CNY | -145.25% |
| 2017 | -331.87 Million CNY | 1.69% |
| 2016 | -337.56 Million CNY | -516.35% |
| 2015 | -54.76 Million CNY | 74.43% |
| 2014 | -214.21 Million CNY | -21.86% |
| 2013 | -175.79 Million CNY | -45.51% |
| 2012 | -120.81 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -418.66 Million CNY | 45.7% |
| 2024 Q1 | -729.98 Million CNY | 23.43% |
| 2024 Q2 | -448.63 Million CNY | 38.54% |
| 2023 Q3 | -928.29 Million CNY | 14.06% |
| 2023 FY | -953.41 Million CNY | 21.62% |
| 2023 Q2 | -1.08 Billion CNY | -3.13% |
| 2023 Q1 | -1.04 Billion CNY | 13.89% |
| 2023 Q4 | -953.41 Million CNY | -2.71% |
| 2022 Q3 | -632.66 Million CNY | 53.45% |
| 2022 Q2 | -1.35 Billion CNY | 10.63% |
| 2022 Q1 | -1.52 Billion CNY | -0.94% |
| 2022 FY | -1.21 Billion CNY | 19.27% |
| 2022 Q4 | -1.21 Billion CNY | -92.26% |
| 2021 Q1 | -1.04 Billion CNY | 23.59% |
| 2021 Q3 | -974.62 Million CNY | 32.19% |
| 2021 Q4 | -1.5 Billion CNY | -54.59% |
| 2021 FY | -1.5 Billion CNY | -10.28% |
| 2021 Q2 | -1.43 Billion CNY | -37.68% |
| 2020 Q2 | -1.55 Billion CNY | -12.6% |
| 2020 FY | -1.36 Billion CNY | 37.94% |
| 2020 Q3 | -1.25 Billion CNY | 19.07% |
| 2020 Q1 | -1.37 Billion CNY | 37.39% |
| 2020 Q4 | -1.36 Billion CNY | -8.78% |
| 2019 FY | -2.2 Billion CNY | -170.48% |
| 2019 Q1 | -697.39 Million CNY | 14.32% |
| 2019 Q2 | -680.05 Million CNY | 2.49% |
| 2019 Q3 | -664.96 Million CNY | 2.22% |
| 2019 Q4 | -2.2 Billion CNY | -231.06% |
| 2018 Q1 | 726.87 Million CNY | 0.0% |
| 2018 FY | -813.91 Million CNY | -145.25% |
| 2018 Q4 | -813.91 Million CNY | 0.0% |
| 2017 Q1 | -99.02 Million CNY | -189.38% |
| 2017 Q2 | -99.02 Million CNY | 0.0% |
| 2017 FY | -331.87 Million CNY | 1.69% |
| 2016 Q2 | 237.9 Million CNY | 0.0% |
| 2016 Q4 | 110.78 Million CNY | 0.0% |
| 2016 Q3 | 110.78 Million CNY | -53.43% |
| 2016 Q1 | 237.9 Million CNY | 18.81% |
| 2016 FY | -337.56 Million CNY | -516.35% |
| 2015 Q2 | -38.23 Million CNY | 0.0% |
| 2015 Q3 | 200.23 Million CNY | 623.76% |
| 2015 Q4 | 200.23 Million CNY | 0.0% |
| 2015 Q1 | -38.23 Million CNY | 82.15% |
| 2015 FY | -54.76 Million CNY | 74.43% |
| 2014 FY | -214.21 Million CNY | -21.86% |
| 2014 Q3 | -214.21 Million CNY | -15.66% |
| 2014 Q1 | -185.2 Million CNY | -5.35% |
| 2014 Q2 | -185.2 Million CNY | 0.0% |
| 2014 Q4 | -214.21 Million CNY | 0.0% |
| 2013 FY | -175.79 Million CNY | -45.51% |
| 2013 Q2 | -107.67 Million CNY | 0.0% |
| 2013 Q1 | -107.67 Million CNY | 10.87% |
| 2013 Q4 | -175.79 Million CNY | 0.0% |
| 2013 Q3 | -175.79 Million CNY | -63.26% |
| 2012 FY | -120.81 Million CNY | 0.0% |
| 2012 Q4 | -120.81 Million CNY | 0.0% |
| 2012 Q3 | -120.81 Million CNY | 0.0% |